Comparative of the Effectiveness and Safety of Biological Agents, Tofacitinib, and Fecal Microbiota Transplantation in Ulcerative Colitis: Systematic Review and Network Meta-Analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative of the Effectiveness and Safety of Biological Agents, Tofacitinib, and Fecal Microbiota Transplantation in Ulcerative Colitis: Systematic Review and Network Meta-Analysis
Authors
Keywords
-
Journal
IMMUNOLOGICAL INVESTIGATIONS
Volume -, Issue -, Pages 1-15
Publisher
Informa UK Limited
Online
2020-02-03
DOI
10.1080/08820139.2020.1714650
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation
- (2019) Cheuk Yin Lai et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis
- (2019) Samuel P. Costello et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease – An Overview of Human Studies
- (2019) Paulo José Basso et al. Frontiers in Pharmacology
- Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease
- (2019) Abhinav Vasudevan et al. INFLAMMATORY BOWEL DISEASES
- Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis
- (2019) Xiao Ding et al. DRUG SAFETY
- Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent Clostridium difficile infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials
- (2019) Abdullah A Alhifany et al. BMJ Open
- Intensified Th9 Response is Associated with the Immunopathogenesis of Active Ulcerative Colitis
- (2018) Mojtaba Shohan et al. IMMUNOLOGICAL INVESTIGATIONS
- European consensus conference on faecal microbiota transplantation in clinical practice
- (2017) Giovanni Cammarota et al. GUT
- Pregnane X Receptor Polymorphisms and Risk of Inflammatory Bowel Disease: A Meta-Analysis
- (2017) Xiaolan Guo et al. IMMUNOLOGICAL INVESTIGATIONS
- Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease
- (2017) Nasser Ebrahimi Daryani et al. IMMUNOLOGICAL INVESTIGATIONS
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
- (2017) Siew C Ng et al. LANCET
- Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
- (2017) Sudarshan Paramsothy et al. LANCET
- Ulcerative colitis
- (2017) Ryan Ungaro et al. LANCET
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Su1737 Clinical Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection From an International Public Stool Bank: Results From a 1,406 Patient Multi-Center Cohort
- (2016) Kelsey O'Brien et al. GASTROENTEROLOGY
- Sa1093 Assessing the Landscape of Fecal Microbiota Transplantation Programs for Recurrent Clostridium difficile Infection: A Survey of Existing Practices Among Healthcare Centers Using an International Public Stool Bank
- (2016) Daniel Martin et al. GASTROENTEROLOGY
- The safety of vedolizumab for ulcerative colitis and Crohn's disease
- (2016) Jean-Frédéric Colombel et al. GUT
- Tofacitinib in ulcerative colitis
- (2016) Thomas P Archer et al. Immunotherapy
- Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection
- (2016) Christine H. Lee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis
- (2015) P. Rutgeerts et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
- (2015) Noortje G. Rossen et al. GASTROENTEROLOGY
- Low-dose Infliximab for Induction and Maintenance Treatment in Chinese Patients With Moderate to Severe Active Ulcerative Colitis
- (2015) Xue-Liang Jiang et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease
- (2015) Severine Vermeire et al. Journal of Crohns & Colitis
- First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis—results from a multicenter prospective randomized controlled trial and its post hoc analysis
- (2015) Taku Kobayashi et al. JOURNAL OF GASTROENTEROLOGY
- Efficacy and Safety of Antiintegrin Antibody for Inflammatory Bowel Disease
- (2015) Lianjie Lin et al. MEDICINE
- The global burden of IBD: from 2015 to 2025
- (2015) Gilaad G. Kaplan Nature Reviews Gastroenterology & Hepatology
- Epidemiology and risk factors for IBD
- (2015) Ashwin N. Ananthakrishnan Nature Reviews Gastroenterology & Hepatology
- Biologics in inflammatory bowel disease: what are the data?
- (2015) Justin Côté-Daigneault et al. United European Gastroenterology Journal
- OpenBiome remains open to serve the medical community
- (2014) Mark Smith et al. NATURE BIOTECHNOLOGY
- Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases
- (2014) Aurelien Amiot et al. Therapeutic Advances in Gastroenterology
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
- (2013) Yasuo Suzuki et al. JOURNAL OF GASTROENTEROLOGY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study
- (2012) Mirthe Emilie van der Valk et al. GUT
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Practical Usefulness of Minor Grooves of the Hepatic Surface for Liver Resection
- (2011) Jae Hoon Lee et al. HEPATO-GASTROENTEROLOGY
- Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts
- (2010) B. Jharap et al. INFLAMMATORY BOWEL DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now